期刊文献+

左卡尼丁和疏血通治疗慢性肾功能不全的临床观察 被引量:1

The Clinical Observation of L-carnionc and Shuxuetong on Chronic Renal Failure
下载PDF
导出
摘要 目的观察左卡尼丁和疏血通治疗慢性肾功能不全的疗效。方法 98例非透析治疗的轻、中度慢性肾功能不全患者被随机分成3组,即左卡尼丁组、疏血通组和联合用药组(合用左卡尼丁和疏血通),治疗4周后观察肾功能多项指标的变化。结果 3组治疗后较治疗前血肌酐、尿素氮、超敏C-反应蛋白、尿微量白蛋白均有下降(P<0.05),其中联合用药组下降更为明显(P<0.01);3组治疗前后比较尿蛋白变化无统计学意义。结论左卡尼丁和疏血通对慢性肾功能不全均有治疗作用,但联合用药效果更佳。 Objective To study the clinical effects of L-carnionc and Shuxuetong on chronic renal failure.Method 98 patients of light or moderate chronic renal failure with non-dialysis therapy were randomly divided into three groups,i.e.L-carnionc group,treated only with L-carnionc,and Shuxuetong group,with Shuxuetong.The third group combined both therapies.The index of renal function were evaluated after 4-week treatment.Results After 4-week treatment there were decreases of the Scr、Bun、hs-CRP、mAlb in 3 groups(P〈0.05 or P〈0.01)and there were no significant difference in UP before and after treatment in 3 groups.Conclusion L-carnionc and Shuxue tong are effective to the chronic renal failure.
作者 李莹
出处 《保健医学研究与实践》 2010年第2期36-38,共3页 Health Medicine Research and Practice
关键词 左卡尼丁 疏血通 慢性肾功能不全 L-carnionc Shuxuetong Chronic renal failure
  • 相关文献

参考文献12

  • 1王小娟,郭建生,雷颖,郭璇,夏历.肾衰颗粒对慢性肾功能不全患者血液流变学的影响及疗效观察[J].中国中医药信息杂志,2007,14(2):12-13. 被引量:10
  • 2Barzilay J I,Abraham I,Heckberts R,et al.The relation of inflammation to the development of glocose disorders in the eldely:the cardiovascular health study[J].Diabetes,2001,50(10):2384-2389.
  • 3商永芳,张蓉,徐倩,李莉,许爱梅.早期糖尿病肾病患者血清超敏CRP水平的变化[J].临床医药实践,2006,15(4):267-268. 被引量:11
  • 4George T,Stylianos C,Anastasios I,et al.Detection of Chlarnydia pnetmoniae in peripheral blood mononuclear cells:correlation with inflammation and atherosclerosis in haemodialysis patients[J].Nephrol Dial Transplant,2003,18(5):918-923.
  • 5Thomas S M,Vibeai G C.Cardiovascular risk in diabetic kidney disease:A mode of chronic renal disease[J].Kidney Int,2005,68(Supp198):18-20.
  • 6Diereks G F,Van Boven A J,HiHege J L,et al.The importance of microalbuminuria as a cardiovascular ris kindicator:A review[J].Can J Cario1,2002,18(5):525-535.
  • 7De Zeeuw.Parving H H,Henning R H.Microalbuminuria as an early Marker for cardiovascular disease[J].J Am Soc Nephrol,2006,17(8):2100-2105.
  • 8Wada M,Nagasawa H,Kurita K,et al.Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects[J].J Neuml Sci,2007,255(1-2):27-34.
  • 9Klausen K P,Scharling H,Jensen J S.Very low level of microalbuminuria is associated with increased fisk of death in subjeeets with eardiovascu-1ar or cerebrovascular disease[J].J Intem Med,2006,260(3):231-237.
  • 10杨少玲,朱旅云,王秀慧.初诊2型糖尿病患者尿微量白蛋白与血管内皮功能的关系[J].临床内科杂志,2009,26(5):324-326. 被引量:3

二级参考文献27

共引文献34

同被引文献7

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部